Search Results
Feb 24, 2026, 16:00 ET Reconfirma autoridad europea que sucralosa es segura: MexBeb
Con base en esta revisión, la autoridad europea concluyó que la sucralosa es segura y mantiene el margen de Ingestión Diaria Admisible (IDA) en 15 mg de sucralosa por kilogramo de peso corporal, por día. Esto equivale a un consumo diario de hasta 12 latas de 355 ml a lo largo de toda una vida, de las
More news about: MexBeb
Feb 24, 2026, 13:09 ET Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States
received approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA) for Brivaracetam Oral Solution 10 mg/mL. Brivaracetam is the bioequivalent to Briviact® Oral Solution, 10 mg/mL, of UCB, Inc. and is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
More news about: Lupin Pharmaceuticals
Feb 24, 2026, 09:35 ET Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
change from baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) scores between the 25 mg and 1 mg groups at Week 6. Two fixed doses – administered 3 weeks apart – of COMP360 25 mg versus 1 mg demonstrated a highly statistically significant reduction in symptom severity with a p-value of <0.001
More news about: Market News Updates
Feb 24, 2026, 09:05 ET New Research Finds Heart Health Benefits in Combining Mango and Avocado Daily
contributes heart-healthy fats (6g unsaturated fats), which can lower the risk of heart disease by helping to reduce LDL cholesterol, and potassium (250mg, 6% DV), important for maintaining healthy blood pressure.The complementary nutrient profiles of these two fruits offer a simple, satisfying
More news about: The National Mango Board
Feb 24, 2026, 08:56 ET Ryde: Invests in the Future of College Athletes with Launch of New Collegiate Program in Partnership with Baylor Athletics
cure, or prevent any disease. Not recommended for individuals under the age of 18 or those sensitive to caffeine. Focus includes 150 mg caffeine and Energize includes 200 mg of caffeine. Do not consume more than two shots per day or in combination. Please check label before consumption to see if Ryde: is
More news about: Ryde:
Feb 24, 2026, 08:00 ET Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access
wholesale acquisition cost (WAC), of Wegovy® (semaglutide) injection 2.4 mg and tablets 25 mg, Ozempic® (semaglutide) injection 0.5 mg, 1 mg, and 2 mg, and Rybelsus® (semaglutide) tablets 7 mg or 14 mg to $675, representing reductions of approximately 50% and 35% for Wegovy®
More news about: NOVO NORDISK INC.
Feb 23, 2026, 16:05 ET BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results
demonstrating 5.0% mean absolute dystrophin expression (without double-correction for histologic adjustment for muscle content) at week 25 in the 9 mg/kg cohort. The 12 mg/kg dose cohort continues to enroll participants, with topline data readout from this cohort expected in 2H'26.Growth
More news about: BioMarin Pharmaceutical Inc.
Feb 23, 2026, 13:13 ET Be LOVE™ Launches Nationwide at Target, Bringing Clean, Everyday Electrolyte Drinks and Real-World Impact to Shelves Across the U.S.
caffeine, and no artificial ingredients, The formula features an intentionally light fruit essence and a high-performance mineral profile—including 220mg of sodium from sea salt, plus magnesium and potassium—to help you feel clear, refreshed, and hydrated without the overwhelming sweetness of traditional
More news about: Be LOVE™
Feb 23, 2026, 10:49 ET Hach Unveils NP6000sc Phosphate Analyzer, Redefining Reliability and Simplifying Compliance for Water Treatment Facilities
NP6000sc Phosphate Analyzer delivers greater confidence in process performance through continuous, precise measurement across three ranges (0.015–75 mg/L) enabling operators to achieve lab-grade accuracy directly in the process.The NP6000sc addresses this directly through an innovative filtration
More news about: Hach
Feb 23, 2026, 09:00 ET Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen
effective for use in children.Zepbound is available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg doses. The 2.5 mg is a starting dose and not an approved maintenance dose. The recommended maintenance doses are 5 mg, 10 mg, or 15 mg injected subcutaneously once per week for weight reduction and
More news about: Eli Lilly and Company
Feb 23, 2026, 08:06 ET Hach Unveils NP6000sc Phosphate Analyzer, Redefining Reliability and Simplifying Compliance for Water Treatment Facilities
NP6000sc Phosphate Analyzer delivers greater confidence in process performance through continuous, precise measurement across three ranges (0.015–75 mg/L) enabling operators to achieve lab-grade accuracy directly in the process.The NP6000sc addresses this directly through an innovative filtration
More news about: Hach
Feb 23, 2026, 08:06 ET Hach wprowadza na rynek analizator fosforanów NP6000sc - nowy standard niezawodności oraz prostsza eksploatacja zapewniają niezawodne pomiary pozwalając kontrolować poprawność procesu technologicznego pod kątem spełniania norm prawnych.
analizatora fosforanów NP6000sc zwiększa pewność kontroli procesu technologicznego dzięki ciągłym, precyzyjnym pomiarom w trzech zakresach (0,015-75 mg/L), umożliwiając uzyskanie dokładności wyniku klasy laboratoryjnej bezpośrednio w układzie technologicznym.NP6000sc wychodzi naprzeciw wyzwaniom
More news about: Hach
Feb 23, 2026, 08:06 ET Hach stellt den Phosphat-Analysator NP6000sc vor, der neue Maßstäbe in Sachen Zuverlässigkeit setzt und die Einhaltung von Vorschriften für Wasseraufbereitungsanlagen vereinfacht
NP6000sc Phosphat-Analysators sorgt für mehr Vertrauen in die Prozessleistung durch kontinuierliche, präzise Messungen in drei Bereichen (0,015–75 mg/l), sodass Bediener direkt im Prozess eine Genauigkeit auf Laborqualität erreichen können.Der NP6000sc löst dieses Problem direkt durch ein innovatives
More news about: Hach
Feb 23, 2026, 08:06 ET Hach onthult NP6000sc Phosphate Analyser en herdefinieert betrouwbaarheid en vereenvoudigt compliance voor waterzuiveringsinstallaties
van de NP6000sc Phosphate Analyser zorgt voor meer vertrouwen in procesprestaties door continue en nauwkeurige metingen over drie bereiken (0,015–75 mg/L), waardoor operators laboratoriumwaardige nauwkeurigheid direct in het proces kunnen bereiken.De NP6000sc pakt dit direct aan via een innovatief
More news about: Hach
Feb 23, 2026, 08:06 ET Hach presenta NP6000sc, l'analizzatore di fosfati che ridefinisce l'affidabilità e semplifica la conformità normativa per gli impianti di trattamento delle acque
fosfati NP6000sc introduce una maggiore affidabilità nelle prestazioni di processo grazie a misurazioni continue e precise su tre intervalli (0,015-75 mg/L). In questo modo, gli operatori possono ottenere direttamente nel processo un livello di precisione paragonabile a quello di laboratorio.L'NP6000sc
More news about: Hach
Feb 23, 2026, 08:06 ET Hach presenta el analizador de fosfatos NP6000sc
analizador de fosfatos NP6000sc ofrece mayor confianza en el rendimiento del proceso mediante mediciones continuas y precisas en tres rangos (0,015–75 mg/L), lo que permite a los operadores lograr una precisión de laboratorio directamente en el proceso.El NP6000sc aborda este problema directamente
More news about: Hach
Feb 23, 2026, 08:06 ET Hach dévoile l'analyseur d'ortho-phosphates NP6000sc, redéfinissant la fiabilité et simplifiant la conformité pour les installations de traitement de l'eau.
l'analyseur de phosphate NP6000sc renforce la confiance dans les performances du procédé grâce à une mesure continue et précise sur trois gammes (0,015–75 mg/L), permettant aux opérateurs d'atteindre une précision de niveau laboratoire directement sur le procédé.Le NP6000sc répond à ces enjeux grâce à
More news about: Hach
Feb 23, 2026, 08:00 ET Omalizumab Triggers T Cell Modification, Increasing the Reaction Thresholds to Common Food Allergens
participants passing the 600 mg peanut challenge had lower IL-4⁺peanut-reactive T cell frequencies than those who failed. After Stage 2, in the omalizumab plus placebo OIT group, higher mDC/pDC frequencies in peanut-stimulated cultures were observed by researchers for those passing the 2000 mg challenge compared
More news about: American Academy of Allergy, Asthma & Immunology (AAAAI)
Feb 23, 2026, 08:00 ET ITF Therapeutics LLC Announces Multiple Data Presentations at 2026 MDA Clinical and Scientific Conference
Monitor triglycerides at 1 month, 3 months, 6 months, and then every 6 months thereafter. Modify the dosage if fasting triglycerides are verified >300 mg/dL. Treatment with DUVYZAT should be discontinued if triglycerides remain elevated despite adequate dietary intervention and dosage adjustment. Gastrointestinal Disturbances:
More news about: ITF Therapeutics LLC
Feb 23, 2026, 07:07 ET RED BULL REVEALS THE NEW RED BULL® SPRING EDITION CHERRY SAKURA
178 countries worldwide, and more than 13.9 billion cans of Red Bull were consumed in 2025 alone. One 8.4 fl oz can of Red Bull Energy Drink contains 80mg of caffeine, about the same as in a home-brewed cup of coffee. For more information, visit
More news about: Red Bull
Feb 22, 2026, 08:00 ET Omalizumab is as Effective as Multi-Food Oral Immunotherapy for Allergenic Food Tolerability
following multi-food oral immunotherapy (mOIT) or omalizumab treatment. Researchers defined the success of DC plans as participants consuming a median of 300 mg/day of allergenic food at three and six months per daily diary records and using study team evaluations conducted over 12 months."The OUtMATCH
More news about: American Academy of Allergy, Asthma & Immunology (AAAAI)
Feb 21, 2026, 08:00 ET TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
1-800-FDA-1088.Dosage Forms and Strengths: TREMFYA® is available as 100 mg/mL and 200 mg/2mL for subcutaneous injection and as a 200 mg/20 mL (10 mg/mL) single dose vial for intravenous infusion.WHAT IS STELARA® (ustekinumab)?STELARA® is
More news about: Johnson & Johnson
Feb 20, 2026, 12:13 ET O ano começou de verdade! Conheça tratamentos que vão cuidar da sua pele em 2026
fundamental consultar um dermatologista que poderá indicar o melhor plano de tratamentos, de acordo com cada caso", explica o dermatologista Bruno Vargas (CRM-MG 38959/ RQE 32477).Nesse contexto, tratamentos que atuam na regeneração profunda da pele se tornam grandes aliados. Sculptra® emerge como uma
More news about: Galderma
Feb 20, 2026, 09:01 ET PRODUCT OF THE YEAR USA UNVEILS 2026 AWARD WINNERS
BeverageProtein Snack | Tyson® Chicken CupsRice | Ben's Original™ Single-Serve Rice CupsSmokeless Tobacco | FRE Lush 15mg Mega PackSpreadable Cheese | Rondelé by PrésidentToothpaste | TheraBreath ToothpasteTopical Pain Relief |
More news about: Product of the Year
Feb 19, 2026, 17:31 ET Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
findings from the first of two pivotal Phase 3 trials in its UP-AA clinical program, assessing the safety and efficacy of upadacitinib (RINVOQ; 15 mg and 30 mg once daily) in adult and adolescent patients with severe alopecia areata, who had a mean baseline SALT score of 83.8, indicating approximately 16%
More news about: DelveInsight Business Research, LLP